Inventor · disambiguated record
Christine I. Wooddell
Also filed as: WOODDELL CHRISTINE · WOODDELL CHRISTINE I
14 granted patents·12 pending applications·138 citations·filing 2001–2024
92Inventor score
Top patents by PatentIndex Score
26 records- 0196US10450565B2Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of useARROWHEAD PHARMACEUTICALS INC·Filed 2018·Granted Oct 22, 2019·15 cites·39 claims
- 0296US10130651B2RNAi Therapy for Hepatitis B Virus InfectionARROWHEAD PHARMACEUTICALS INC·Filed 2016·Granted Nov 20, 2018·22 cites·18 claims
- 0395US11884920B2Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of useARROWHEAD PHARMACEUTICALS INC·Filed 2021·Granted Jan 30, 2024·2 cites·21 claims
- 0495US7262056B2Enhancing intermolecular integration of nucleic acids using integrator complexesMIRUS BIO CORP·Filed 2002·Granted Aug 28, 2007·68 cites·9 claims
- 0594US12188017B2Compositions and methods for inhibiting gene expression of alpha-1 antitrypsinARROWHEAD PHARMACEUTICALS INC·Filed 2022·Granted Jan 7, 2025·1 cites·12 claims
- 0694US11517584B2RNAi agents for Hepatitis B virus infectionARROWHEAD PHARMACEUTICALS INC·Filed 2021·Granted Dec 6, 2022·2 cites·58 claims
- 0792US11590156B2RNAi agents for hepatitis B virus infectionARROWHEAD PHARMACEUTICALS INC·Filed 2020·Granted Feb 28, 2023·2 cites·37 claims
- 0892US11203756B2Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of useARROWHEAD PHARMACEUTICALS INC·Filed 2019·Granted Dec 21, 2021·5 cites·25 claims
- 0992US10780108B2RNAi agents for Hepatitis B virus infectionARROWHEAD PHARMACEUTICALS INC·Filed 2017·Granted Sep 22, 2020·5 cites·67 claims
- 1091US11384355B2Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsinARROWHEAD PHARMACEUTICALS INC·Filed 2019·Granted Jul 12, 2022·3 cites·23 claims
- 1190US2025197861A1Compositions and methods for inhibiting gene expression of alpha-1 antitrypsinARROWHEAD PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1289US10806750B2RNAi therapy for hepatitis B virus infectionARROWHEAD PHARMACEUTICALS INC·Filed 2018·Granted Oct 20, 2020·3 cites·9 claims
- 1388US10006025B2Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsinARROWHEAD MADISON INC·Filed 2015·Granted Jun 26, 2018·5 cites·25 claims
- 1484US2024141351A1Alpha-1 antitrypsin (aat) rnai agents, compositions including aat rnai agents, and methods of useARROWHEAD PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1580US2023355651A1Rnai agents for hepatitis b virus infectionARROWHEAD PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1679US2023355654A1Rnai therapy for hepatitis b virus infectionARROWHEAD PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1777US8021875B2Methods for expression of transgenesROCHE MADISON INC·Filed 2002·Granted Sep 20, 2011·5 cites·5 claims
- 1871US11534453B2RNAi therapy for hepatitis B virus infectionARROWHEAD PHARMACEUTICALS INC·Filed 2020·Granted Dec 27, 2022·0 cites·25 claims
- 1969US2024392292A1RNAi Agents for Inhibiting Expression of Coronavirus (CoV) Viral Genomes, Compositions Thereof, and Methods of UseARROWHEAD PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2064US2019255091A1RNAi AGENTS FOR HEPATITIS B VIRUS INFECTIONARROWHEAD PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2163US2018258430A1Compositions and Methods for Inhibiting Gene Expression of Alpha-1 AntiTrypsinARROWHEAD PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2250US2005196862A1DNA cassette for cellular expression of small RNAFiled 2003·Application pending·0 cites
- 2347US2003143740A1Processes for transposase mediated integration into mammalian cellsFiled 2002·Application pending·0 cites
- 2444US2017056472A1Peptide-Based In Vivo siRNA Delivery SystemARROWHEAD PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2544US2019071670A1Methods Of Treatment For Alpha-1 Antitrypsin DeficiencyARROWHEAD PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2643US2002061861A1Nucleic acid expression from linear nucleic acidsFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christine I. Wooddell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →